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It was not more than a few years ago that it was common
to encounter arguments among scientists as to the merits
of whole genome sequencing. Now, only three short years
since the first whole genome of a free-living organism was
sequenced [1], these doubting arguments seem almost
ludicrous. Genomics — the science based on the sequenc-
ing of whole genomes — has revolutionized the approach
to many of the most important questions in basic biology
and medicine (as introduced in the keynote lecture by
Wally Gilbert of Harvard University). So much so, in fact,
that it now seems difficult to remember the molecular
biology of the pre-genomics world. But, of course, current
day genomics is based on linear sequence data, and this
places certain limitations on its value in understanding the
three-dimensional universe inhabited by biological mol-
ecules. These limitations may soon be at an end, however,
for another revolution is upon us: the birth of the new
science of structural genomics.
The primary goal of structural genomics is to provide the
science of structural biology with the same kind of
panoramic understanding that sequence genomics has
added to the linear information content of the genome.
The recent Structural Genomics Workshop held at the
Advanced Photon Source (APS) at Argonne National
Laboratory brought together about seventy structural
biologists (including computational biologists and bio-
informatics experts), most of whom had more-or-less inde-
pendently come to the conclusion that this idea had come
of age, and that the time to seriously think about its imple-
mentation has arrived.
Structural genomics, for the most part, is still in the plan-
ning stage. Like the Human Genome Project, this is
another novel foray of biologists into ‘big science’, and
hence its birth must be induced by meetings intended, at
least in part, to organize a unified assault. But it is still early
days, and the main discussions at the Structural Genomics
Workshop addressed the core scientific issue: what can be
learned from structural genomics? Are we truly at the dawn
of a new revolution, or will three-dimensional structures
provide only an incremental advance over sequence-based
knowledge? Even so, assuming (as the attendees univer-
sally seemed to conclude) that amassing a comprehensive
structure database will be of immense value, how can it be
achieved, and what new insight will it provide?
The class-based approach
What might constitute a comprehensive structural data-
base? (This issue was directly addressed in the presenta-
tions of Andrej Sali of Rockefeller University, Chris
Sander, now at Millennium Pharmaceuticals, and Eugene
Koonin of NCBI). There are thought to be about 100,000
expressed proteins encoded by the human genome (the
so-called ‘proteome’). Must we solve all of these struc-
tures? Even if we were to accomplish this herculean task,
would it be enough? What would these structures tell us
about the proteins of bacteria, or yeast, or archaea, or
plants? Of course this issue is a straw man that was easily
blown down (by almost every speaker) at Argonne.
Sequence-based genomics has enabled exhaustive
arrangement of proteins, across genomes and across
species, into classes. Determination of the structure of a
representative member from each and every class, it is rea-
soned, should provide a comprehensive view, at some
level, of all expressed proteins. There are, of course, some
caveats here. What constitute these protein classes? Do
they comprise whole proteins, domains or sequence motifs
that may — or may not — correspond to independent
modules? Are all protein classes accessible, for example,
will integral membrane proteins eventually succumb to
mass structure determination? These are evolving issues
that doubtless will be pragmatically addressed once struc-
tural genomics projects are underway in earnest.
Given this approach, the question of what can be learned
from a comprehensive database of structures can be more
acutely considered in light of the refined question: what
can be gleaned from the structures of one member (or in
some cases multiple members) of each of the structural
classes? Doubtless, as has been amply illustrated by
sequence genomics, the uses of such a database will far
outstrip what can be imagined now in its absence. Even
so, we can imagine quite a lot!
A class-based structural database should enable the
comprehension of all protein folds adopted in nature (with
the exception of families that will not yield to structure
determination, of course). This may bring to light new
functional insights based on structural analysis. Just as
sequence genomics might, for example, enable the identi-
fication of a protein kinase by recognition of a signature
sequence motif, structural genomics will be able to do
this by examining homology in three dimensions. This,
we would expect, should prove far more powerful than
sequence-based approaches. One by-product of a structural
genomics project, therefore, will surely be a flurry of ‘sur-
prise’ structural, and in some cases functional homologies,
to arise which could not be identified on the basis of
sequence alone. This has the potential to elucidate unex-
pected links in biological pathways that might have been
impossible (or at least very hard) to come by through tradi-
tional hypothesis-driven methods. This underscores the
point that structural genomics will be an endeavor that, at
its heart, is a mission of data gathering. We should not have
to be extraordinarily clever to benefit from structural
genomics — because it is neither dependent on nor limited
by our preconceived ideas as to what we might find.
A class-based structural database will also provide an enor-
mous amount of data on how proteins behave — and
should thereby provide an invaluable resource for improv-
ing our understanding of protein folding. The unsolved
members of each class (which will probably constitute the
majority) may still be visualized by homology modeling,
on the basis of the known structures of family representa-
tives. These models should be better than can be
achieved today, due to the availability of the much larger
database that will provide the foundation for modeling
techniques such as secondary structure prediction.
Is that a threat?
Will structural genomics destroy structural biology as we
know it today? Once we have built a comprehensive data-
base of structural classes, will there still be valuable
knowledge to be gained from the determination of indi-
vidual structures? The answer here, of course, is a
resounding yes. The information that we can hope to gain
from structural genomics is of a fundamentally different
character than is provided by traditional structural biology.
The former, hopefully, will provide rare biological insights
in broad-brush strokes as unexpected relationships come
to light, and should also provide an understanding of the
protein motifs or folds of interest in specific biological
problems. This knowledge should actually enhance our
ability to undertake traditional in-depth structural studies.
It is certainly true that the accuracy of computational
structural predictions should improve with the advent of a
comprehensive class database, but even so, the point at
which these approaches can truly replace experimental
structure determination seems remote at best. Tradition-
ally, structural biologists have tried to choose problems
that present important questions of biological function
that can best be answered through a structural under-
standing of the molecular actors. This requires not only
structure determination, but also deep analysis with
respect to the particular functional question. The advent
of structural genomics is certainly no threat to such an
endeavor and, on the contrary, may be an important tool.
How can it be done?
There are several recent advances — both in technology
and comprehension — that have only recently brought
structural genomics into the realm of the possible. The
first of these, as mentioned above, is sequence-based
genomics. This has enabled the intelligent classification of
protein sequences within and across genomes, thus pro-
viding a means to generate a putative list of targets. This
leads into the question that has sparked the most trepida-
tion of all: how will we express all these proteins?
Two of the speakers (Paul Godowski of Genentech and
Sung-Hou Kim of the University of California at Berke-
ley) addressed this issue directly, and presented prelimi-
nary data which was quite encouraging. The first
conclusion is a familiar bromide of science: do the easy
things first. If bacterial class members exist, focus on these
for expression in bacteria. Even better, if proteins from
thermophiles can be expressed in Escherichia coli, substan-
tial purification can usually be achieved by boiling the
recombinant cell extract. Protein classes without identifi-
able bacterial homologues can be tried in bacterial expres-
sion systems, but may ultimately require eukaryotic
systems. In this event, it was suggested that either yeast or
insect cell systems would be most expeditious and eco-
nomical, whereas mammalian cell systems would mostly
be excluded based on these considerations.
This ‘easy ones first’ approach may lead to an early focus
on relatively small proteins that, based on their sequences,
are likely to be soluble. Multidomain proteins and single-
pass transmembrane proteins are likely to pose new
questions of domain definition that can be addressed first
by analytical sequence-based methods, and second by
expression trials, limited proteolysis and mass spectrome-
try studies (a discussion of which was presented by Steve
Burley of Rockefeller University). Integral membrane pro-
teins will probably await advances enabling better
approaches to crystallization or perhaps structure determi-
nation by NMR spectroscopic methods.
How will we solve all these structures? Most of the speakers
seemed to agree that crystallography will be the real work-
horse of structural genomics. Although NMR spectroscopy
should also play a valuable role, it will probably be as a
niche player. Several recent technical advances (summa-
rized in the presentation by Wayne Hendrickson of Colum-
bia University), together, have compounded advantages
which truly equip crystallography for the task of large-scale
structure determination. These include crystal freezing,
MAD phasing (particularly as applied to selenomethionyl
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proteins) and the exceptionally brilliant undulator beam-
lines being constructed at third-generation synchrotrons.
Although technologically the least impressive, crystal
freezing has had an enormous impact on broadening the
range of applicability of X-ray experiments, and particu-
larly for MAD which requires copious amounts of data.
Even fairly poor crystals are now within the reach of
experiments that would once have produced useful data
only for the best capillary mounted crystals. 
MAD phasing of selenomethionyl proteins is almost
certain to become the main structure determination
method of structural genomics. Selenomethionyl proteins
can be expressed easily in most recombinant expression
systems, obviating the often tedious stage of searching for
isomorphous derivatives. Undulator beamlines should
provide very brilliant X-rays at energy resolutions appro-
priate for MAD experiments. Coupled with the use of the
newest generation of CCD detectors, a single MAD
experiment — which provides all the data necessary for a
structure solution — should be obtainable in hours or even
fractions of an hour (as was described by Andrej
Joachimiak of Argonne National Laboratory), rather than
several days, which is the norm.
When, and Who?
The question of the rate at which we can solve these class-
representative structures does not yet have a clear answer.
Why is this? Most importantly, the class-based approach
provides an enormous advantage over the classical one: if a
protein proves to be a difficult target, we can drop it in
favor of one of its classmates that proves to be easier. Tom
Terwilliger (of Los Alamos National Laboratory) sug-
gested the possibility that most structural studies in the
future will benefit from parallel studies on multiple class
members (at least through the expression and crystalliza-
tion stages), following through only on those that work
easily. Given the innumerable ways that structural pro-
jects can falter — and result in delays of months (or
years!) — the advantages of this approach may indeed be
extraordinary. Coupled with the continual technical
advancement of structure determination methods, there is
ample reason for optimism.
One giant question remains: who will take on the task?
The best clues here are probably taken from the role
model of sequence genomics. Consortia of academic labo-
ratories might be organized, dividing groups of targets
among them, or perhaps governmentally funded ‘Struc-
tural Genome Centers’ could be founded. Alternatively,
private organizations analogous to Human Genome Sci-
ences or The Institute for Genomic Research could arise.
Interestingly, the term ‘structural genomics’ (as applied
here) may have had its first public use by the private
Structural Genomics CAT (collaborative access team) at
the APS, which intends to embark on mass-scale structure
determination. Most likely, the Structural Genome Project
will involve a broad mix of participating organizations.
Right now it’s hard to predict exactly how the Structural
Genome Project will be done, but it is easy to predict one
thing with certainty: one way or another, it certainly will
be done.
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